Inventor · disambiguated record
Vivek M. Rangnekar
Also filed as: RANGNEKAR VIVEK · RANGNEKAR VIVEK M
4 granted patents·5 pending applications·5 citations·filing 2003–2023
63Inventor score
Files withUNIV KENTUCKY RES FOUND9
Top patents by PatentIndex Score
9 records- 0175US9873670B2Arylquinoline and analog compounds and use thereof to treat cancerUNIV KENTUCKY RES FOUND·Filed 2014·Granted Jan 23, 2018·2 cites·13 claims
- 0263US10512641B2Chloroquine induction par-4 and treatment of cancerUNIV KENTUCKY RES FOUND·Filed 2016·Granted Dec 24, 2019·1 cites·13 claims
- 0360US2024216555A1Targeting and treatment of cancerous cells using radiolabeled grp78-binding agentsUNIV KENTUCKY RES FOUND·Filed 2023·Application pending·0 cites
- 0452US7786275B2Identification of a unique core domain of Par-4 sufficient for selective apoptosis induction in cancer cellsUNIV KENTUCKY RES FOUND·Filed 2003·Granted Aug 31, 2010·2 cites·4 claims
- 0550US2022153805A1A Novel Prostate Apoptosis Response-4 (Par-4) Protein Entity with an Extended Duration of Action for Therapeutic Treatment of CancerUNIV KENTUCKY RES FOUND·Filed 2020·Application pending·0 cites
- 0649US11730750B2Drugs for GRP78 cell surface translocation and Par-4 secretionUNIV KENTUCKY RES FOUND·Filed 2021·Granted Aug 22, 2023·0 cites·7 claims
- 0746US2022387412A1Novel Superebastine Against Therapy Resistant Prostate CancerUNIV KENTUCKY RES FOUND·Filed 2020·Application pending·0 cites
- 0843US2021046063A1Novel combination of crizotinib with chloroquine for inhibition of diverse lung tumorsUNIV KENTUCKY RES FOUND·Filed 2020·Application pending·0 cites
- 0932US2016332971A1Arylquinoline, arylquinolone and arylthioquinolone derivatives and use thereof to treat cancerUNIV KENTUCKY RES FOUND·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →